Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Intramyocardial injection of autologous bone marrow cells as an adjunctive therapy to incomplete myocardial revascularization--safety issues.

Gowdak LH, Schettert IT, Baptista E, Lopes NL, Rochitte CE, Vieira ML, Grupi CJ, César LA, Krieger JE, de Oliveira SA.

Clinics (Sao Paulo). 2008 Apr;63(2):207-14.

2.

[Cell therapy plus transmyocardial laser revascularization: a proposed alternative procedure for refractory angina].

Dallan LA, Gowdak LH, Lisboa LA, Schettert I, Krieger JE, Cesar LA, Oliveira SA, Stolf NA.

Rev Bras Cir Cardiovasc. 2008 Jan-Mar;23(1):46-52. Portuguese.

PMID:
18719828
3.

Early increase in myocardial perfusion after stem cell therapy in patients undergoing incomplete coronary artery bypass surgery.

Gowdak LH, Schettert IT, Rochitte CE, Lisboa LA, Dallan LA, César LA, de Oliveira SA, Krieger JE.

J Cardiovasc Transl Res. 2011 Feb;4(1):106-13. doi: 10.1007/s12265-010-9234-2.

PMID:
21061106
4.

Transmyocardial laser revascularization plus cell therapy for refractory angina.

Gowdak LH, Schettert IT, Rochitte CE, Rienzo M, Lisboa LA, Dallan LA, César LA, Krieger JE, Ramires JA, de Oliveira SA.

Int J Cardiol. 2008 Jul 4;127(2):295-7. Epub 2007 Jul 31.

PMID:
17669519
5.

Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.

Beeres SL, Bax JJ, Kaandorp TA, Zeppenfeld K, Lamb HJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, de Roos A, van der Wall EE, Schalij MJ, Atsma DE.

Am J Cardiol. 2006 May 1;97(9):1326-31. Epub 2006 Mar 20.

PMID:
16635605
6.

Intracoronary autologous CD34+ stem cell therapy for intractable angina.

Wang S, Cui J, Peng W, Lu M.

Cardiology. 2010;117(2):140-7. doi: 10.1159/000320217. Epub 2010 Oct 23.

7.

Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.

van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ, Atsma DE.

JAMA. 2009 May 20;301(19):1997-2004. doi: 10.1001/jama.2009.685.

PMID:
19454638
8.

Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life.

Mann I, Rodrigo SF, van Ramshorst J, Beeres SL, Dibbets-Schneider P, de Roos A, Wolterbeek R, Zwaginga JJ, Fibbe WE, Bax JJ, Schalij MJ, Atsma DE.

Circ Cardiovasc Interv. 2015 Aug;8(8). pii: e002740. doi: 10.1161/CIRCINTERVENTIONS.115.002740.

9.
10.

Comparative evaluation of long-term clinical efficacy with catheter-based percutaneous intramyocardial autologous bone marrow cell implantation versus laser myocardial revascularization in patients with severe coronary artery disease.

Tse HF, Thambar S, Kwong YL, Rowlings P, Bellamy G, McCrohon J, Bastian B, Chan JK, Lo G, Ho CL, Parker A, Hauser TH, Lau CP.

Am Heart J. 2007 Nov;154(5):982.e1-6. Epub 2007 Sep 6.

PMID:
17967607
11.

Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.

Briguori C, Reimers B, Sarais C, Napodano M, Pascotto P, Azzarello G, Bregni M, Porcellini A, Vinante O, Zanco P, Peschle C, Condorelli G, Colombo A.

Am Heart J. 2006 Mar;151(3):674-80.

PMID:
16504630
12.

The combined use of transmyocardial laser revascularisation and intramyocardial injection of bone-marrow derived stem cells in patients with end-stage coronary artery disease: one year follow-up.

Konstanty-Kalandyk J, Piątek J, Miszalski-Jamka T, Rudziński P, Walter Z, Bartuś K, Urbańczyk-Zawadzka M, Sadowski J.

Kardiol Pol. 2013;71(5):485-92. doi: 10.5603/KP.2013.0095.

13.

Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.

Beeres SL, Bax JJ, Dibbets P, Stokkel MP, Zeppenfeld K, Fibbe WE, van der Wall EE, Schalij MJ, Atsma DE.

J Nucl Med. 2006 Apr;47(4):574-80.

14.

Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia.

Rodrigo SF, van Ramshorst J, Mann I, Leong DP, Cannegieter SC, Al Younis I, Dibbets-Schneider P, de Roos A, Fibbe WE, Zwaginga JJ, Bax JJ, Schalij MJ, Beeres SL, Atsma DE.

Int J Cardiol. 2014 Aug 20;175(3):539-44. doi: 10.1016/j.ijcard.2014.06.039. Epub 2014 Jul 2.

PMID:
25023791
15.

Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up.

Mathiasen AB, Haack-Sørensen M, Jørgensen E, Kastrup J.

Int J Cardiol. 2013 Dec 10;170(2):246-51. doi: 10.1016/j.ijcard.2013.10.079. Epub 2013 Oct 28.

PMID:
24211066
16.

[Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience].

Yerebakan C, Uğurlucan M, Kaminski A, Westphal B, Liebold A, Steinhoff G.

Anadolu Kardiyol Derg. 2009 Dec;9(6):457-64. Turkish.

17.

Safety of intramyocardial injection of autologous bone marrow cells to treat myocardial ischemia in pigs.

Goodchild T, Pang W, Tondato F, Cui J, Otsuka Y, Frowein S, Ungs M, Robinson K, Poznansky M, Chronos N.

Cardiovasc Revasc Med. 2006 Jul-Sep;7(3):136-45.

PMID:
16945820
18.

Bone marrow laser revascularisation for treating refractory angina due to diffuse coronary heart disease.

Reyes G, Allen KB, Aguado B, Duarte J.

Eur J Cardiothorac Surg. 2009 Jul;36(1):192-4. doi: 10.1016/j.ejcts.2009.03.022. Epub 2009 Apr 25.

PMID:
19394846
19.

Intramyocardial, autologous CD34+ cell therapy for refractory angina.

Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA; ACT34-CMI Investigators.

Circ Res. 2011 Aug 5;109(4):428-36. doi: 10.1161/CIRCRESAHA.111.245993. Epub 2011 Jul 7.

20.

[Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia].

Beeres SL, Bax JJ, Stokkel MP, Fibbe WE, van der Wall EE, Schalij MJ, Atsma DE.

Ned Tijdschr Geneeskd. 2006 Jul 8;150(27):1523-7. Dutch.

PMID:
16892617

Supplemental Content

Support Center